Treatment Options for Endometriosis
NSAIDs and hormonal therapies are the first-line treatments for endometriosis, with surgery reserved for cases unresponsive to medical management. 1, 2
First-Line Management
- NSAIDs provide immediate pain relief and should be used at appropriate doses and schedules for optimal control of endometriosis-related pain 3, 1
- Combined hormonal contraceptives (oral, patch, or ring) are effective for pain relief and are equivalent to more costly regimens 1, 4
- Progestins are effective alternatives with similar efficacy to other hormonal treatments:
Second-Line Management
- GnRH agonists provide significant pain relief when used for at least three months 1, 2
- When using GnRH agonists long-term, add-back therapy should be implemented to reduce bone mineral loss without reducing pain relief efficacy 1, 2
- Dienogest, a newer progestin, has become one of the most widely used drugs for all endometriosis phenotypes for long-term treatment 6
- Elagolix, a GnRH antagonist, has recently received FDA approval for treating endometriosis-associated pain 7
Surgical Management
- Surgery provides significant pain reduction during the first six months following the procedure 1, 2
- For severe endometriosis, medical treatment alone may not be sufficient, and surgical intervention should be considered 1, 2
- Up to 44% of women experience symptom recurrence within one year after surgery 1, 2
- Hysterectomy with bilateral salpingo-oophorectomy is currently the only procedure that seems to cure endometriosis 8
Special Considerations
- For women with endometriosis who required oophorectomy, combined estrogen/progestogen therapy can effectively treat vasomotor symptoms and may reduce the risk of disease reactivation 9
- Hormone replacement therapy with estrogen is not contraindicated following hysterectomy and bilateral salpingo-oophorectomy for endometriosis 1
- Despite multiple treatment options, there is no medical therapy proven to completely eradicate endometriosis lesions 3, 2
Emerging Therapies
- Aromatase inhibitors have shown promising results in clinical trials 7
- Other innovative targets are being investigated, but most compounds have only been evaluated in pre-clinical studies or early clinical trials 7
- Antiangiogenic and immune-modulating drugs are being researched as potential nonhormonal therapies 10